{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:23:22Z","timestamp":1790835802524,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI RO1","award":["R01CA193220"],"award-info":[{"award-number":["R01CA193220"]}]},{"name":"NIH\/NCI R50","award":["R50CA211404"],"award-info":[{"award-number":["R50CA211404"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.exphem.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T10:32:25Z","timestamp":1534501945000},"page":"18-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response"],"prefix":"10.1016","volume":"67","author":[{"given":"Aditya","family":"Barve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavona","family":"Casson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Krem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Mulloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-4881","authenticated-orcid":false,"given":"Levi J.","family":"Beverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2018.08.004_bib0001","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.seminhematol.2013.03.029","article-title":"Modeling human hematopoietic stem cell biology in the mouse","volume":"50","author":"Sykes","year":"2013","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2018.08.004_bib0002","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ni1009-1039","article-title":"Renaissance for mouse models of human hematopoiesis and immunobiology","volume":"10","author":"Manz","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2018.08.004_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10555-012-9405-5","article-title":"Animal models of leukemia: any closer to the real thing?","volume":"32","author":"Cook","year":"2013","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.exphem.2018.08.004_bib0004","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/cmi.2012.2","article-title":"Current advances in humanized mouse models","volume":"9","author":"Ito","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.exphem.2018.08.004_bib0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.1771409","article-title":"Mouse models of human AML accurately predict chemotherapy response","volume":"23","author":"Zuber","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2018.08.004_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrc3001","article-title":"Mouse models of advanced spontaneous metastasis for experimental therapeutics","volume":"11","author":"Francia","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2018.08.004_bib0007","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.08.004_bib0008","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2018.08.004_bib0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11899-015-0255-4","article-title":"Targeting the microenvironment in acute myeloid leukemia","volume":"10","author":"Rashidi","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.exphem.2018.08.004_bib0010","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1158\/1078-0432.CCR-07-2223","article-title":"The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance","volume":"14","author":"Meads","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2018.08.004_bib0011","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.08.004_bib0012","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.08.004_bib0013","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.exphem.2018.08.004_bib0014","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S0016672300010168","article-title":"'Nude', a new hairless gene with pleiotropic effects in the mouse","volume":"8","author":"Flanagan","year":"1966","journal-title":"Genet Res"},{"key":"10.1016\/j.exphem.2018.08.004_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/301527a0","article-title":"A severe combined immunodeficiency mutation in the mouse","volume":"301","author":"Bosma","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.08.004_bib0016","doi-asserted-by":"crossref","first-page":"11920","DOI":"10.1073\/pnas.89.24.11920","article-title":"Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II","volume":"89","author":"Dvir","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.08.004_bib0017","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/2159-8290.CD-14-0358","article-title":"Beyond DNA repair: DNA-PK function in cancer","volume":"4","author":"Goodwin","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2018.08.004_bib0018","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Shultz","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2018.08.004_bib0019","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-0-387-69259-3_11","article-title":"Murine models of human acute myeloid leukemia","volume":"145","author":"Fortier","year":"2010","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.exphem.2018.08.004_bib0020","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.08.004_bib0021","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2018.08.004_bib0022","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.immunol.14.1.179","article-title":"The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID","volume":"14","author":"Sugamura","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.exphem.2018.08.004_bib0023","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1182\/blood-2012-10-464677","article-title":"AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model","volume":"121","author":"Wunderlich","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.08.004_bib0024","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","article-title":"Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor {gamma} chain(null) mice","volume":"106","author":"Ishikawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.08.004_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/sj.leu.2402882","article-title":"Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD\/SCID mice and in NOD\/SCID mice transgenic for human growth factors","volume":"17","author":"Feuring-Buske","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.08.004_bib0026","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/leu.2010.158","article-title":"AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3","volume":"24","author":"Wunderlich","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.08.004_bib0027","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4049\/jimmunol.169.1.204","article-title":"Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic\/Shi-scid, IL-2 receptor gamma null mice","volume":"169","author":"Yahata","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2018.08.004_bib0028","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/01.TP.0000083041.44829.2C","article-title":"NOD\/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment","volume":"76","author":"Shultz","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.exphem.2018.08.004_bib0029","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1182\/blood-2014-02-556340","article-title":"OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues","volume":"123","author":"Wunderlich","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.08.004_bib0030","first-page":"158","article-title":"Dissecting the in vivo leukemogenic potency of BCLxl","volume":"2","author":"Saurabh","year":"2014","journal-title":"J Leuk (Los Angel)"},{"key":"10.1016\/j.exphem.2018.08.004_bib0031","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbmt.2014.10.025","article-title":"Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy","volume":"21","author":"Othus","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2018.08.004_bib0032","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.gde.2016.03.011","article-title":"Genetic and epigenetic heterogeneity in acute myeloid leukemia","volume":"36","author":"Li","year":"2016","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2018.08.004_bib0033","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"'Acute myeloid leukemia: a comprehensive review and 2016 update'","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18307513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18307513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:33:19Z","timestamp":1759566799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X18307513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":33,"alternative-id":["S0301472X18307513"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2018.08.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}